{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:29:03Z","timestamp":1760297343517},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,2,27]],"date-time":"2005-02-27T00:00:00Z","timestamp":1109462400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2005,2,27]],"date-time":"2005-02-27T00:00:00Z","timestamp":1109462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Background<\/jats:title>\n                        <jats:p>Although the association between mitral stenosis (MS) and increased coagulation activity is well recognized, it is unclear whether enhanced coagulation remains localized in the left atrium or whether this represents a systemic problem. To assess systemic coagulation parameters and changes in platelet aggregation, we measured fibrinogen levels and performed <jats:italic>in vitro<\/jats:italic> platelet function tests in plasma obtained from mitral stenotic patients' and from healthy control subjects' peripheral venous blood.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Sixteen newly diagnosed patients with rheumatic MS (Group P) and 16 healthy subjects (Group N) were enrolled in the study. Platelet-equalized plasma samples were evaluated to determine <jats:italic>in vitro<\/jats:italic> platelet function, using adenosine diphosphate (ADP), collagen and epinephrine in an automated aggregometer. <jats:italic>In vitro<\/jats:italic> platelet function tests in group N were performed twice, with and without plasma obtained from group P.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>There were no significant differences between the groups with respect to demographic variables. Peripheral venous fibrinogen levels in Group P were not significantly different from those in Group N. Adenosine diphosphate, epinephrine and collagen-induced platelet aggregation ratios were significantly higher in Group P than in Group N. When plasma obtained from Group P was added to Group N subjects' platelets, ADP and collagen-induced, but not epinephrine-induced, aggregation ratios were significantly increased compared to baseline levels in Group N.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>Platelet aggregation is increased in patients with MS, while fibrinogen levels remain similar to controls. We conclude that mitral stenotic patients exhibit increased systemic coagulation activity and that plasma extracted from these patients may contain some transferable factors that activate platelet aggregation.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/1468-6708-6-2","type":"journal-article","created":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T07:25:29Z","timestamp":1109661929000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Presence of factors that activate platelet aggregation in mitral stenotic patients' plasma"],"prefix":"10.1186","volume":"6","author":[{"given":"Istemihan","family":"Tengiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ertugrul","family":"Ercan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahri","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emin","family":"Alioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Duman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guray","family":"Saydam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filiz","family":"Buyukkececi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,2,27]]},"reference":[{"key":"121_CR1","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1378\/chest.106.2.396","volume":"106","author":"CW Chiang","year":"1994","unstructured":"Chiang CW, Lo SK, Kuo CT, Cheng NJ, Hsu TS: Noninvasive predictors of systemic embolism in mitral stenosis. An echocardiographic and clinical study of 500 patients. Chest. 1994, 106: 396-399.","journal-title":"Chest"},{"key":"121_CR2","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1136\/pgmj.47.551.599","volume":"47","author":"HA Fleming","year":"1995","unstructured":"Fleming HA, Bailey SM: Mitral valve disease, systemic embolism and anti-coagulants. Postgrad Med J. 1995, 47: 599-604.","journal-title":"Postgrad Med J"},{"key":"121_CR3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1177\/000331970305400509","volume":"54","author":"R Atak","year":"2003","unstructured":"Atak R, Yetkin E, Yetkin O, Ayaz S, Ileri M, Senen K, Turhan H, Erbay AR, Cehreli S: Increased systemic and regional coagulation activity in patients with mitral stenosis and sinus rhythm. Angiology. 2003, 54: 593-597.","journal-title":"Angiology"},{"key":"121_CR4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0002-9149(97)01025-4","volume":"81","author":"M Ileri","year":"1998","unstructured":"Ileri M, Buyukasik Y, Ileri NS, Haznedaroglu IC, Goksel S, Kirazli S, Dundar S: Activation of blood coagulation in patients with mitral stenosis and sinus rhythm. Am J Cardiol. 1998, 81: 795-797. 10.1016\/S0002-9149(97)01025-4.","journal-title":"Am J Cardiol"},{"key":"121_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1161\/01.CIR.94.3.331","volume":"94","author":"RE Peverill","year":"1996","unstructured":"Peverill RE, Harper RW, Gelman J, Gan TE, Harris G, Smolich JJ: Determinants of increased regional left atrial coagulation activity in patients with mitral stenosis. Circulation. 1996, 94: 331-339.","journal-title":"Circulation"},{"key":"121_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0735-1097(94)00322-H","volume":"25","author":"K Yamamoto","year":"1995","unstructured":"Yamamoto K, Ikeda U, Seino Y, Mito H, Fujikawa H, Sekiguchi H, Shimada K: Coagulation activity is increased in the left atrium of patients with mitral stenosis. J Am Coll Cardiol. 1995, 25: 107-112. 10.1016\/0735-1097(94)00322-H.","journal-title":"J Am Coll Cardiol"},{"key":"121_CR7","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/S0002-9149(99)00060-0","volume":"83","author":"FL Li-Saw-Hee","year":"1999","unstructured":"Li-Saw-Hee FL, Blann AD, Goldsmith I, Lip GY: Indexes of hypercoagulability measured in peripheral blood in patients with atrial fibrillation secondary to mitral stenosis. Am J Cardiol. 1999, 83: 1206-1209. 10.1016\/S0002-9149(99)00060-0.","journal-title":"Am J Cardiol"},{"key":"121_CR8","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/01.CIR.58.6.1072","volume":"58","author":"DJ Sahn","year":"1978","unstructured":"Sahn DJ, De Maria A, Kisslo J, Weyman A: Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978, 58: 1072-1083.","journal-title":"Circulation"},{"key":"121_CR9","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1161\/01.CIR.60.5.1096","volume":"60","author":"L Hatle","year":"1979","unstructured":"Hatle L, Angelsen B, Tromsdal A: Noninvasive assessment of atrioventricular pressure half-time by Doppler ultrasound. Circulation. 1979, 60: 1096-1104.","journal-title":"Circulation"},{"key":"121_CR10","first-page":"550","volume":"82","author":"I Hayashi","year":"1991","unstructured":"Hayashi I: Laboratory diagnosis of left atrial thrombi in patients with mitral stenosis. Fukuoka Igaka Zasshi. 1991, 82: 550-561.","journal-title":"Fukuoka Igaka Zasshi"},{"key":"121_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1136\/hrt.66.1.22","volume":"66","author":"M Yasaka","year":"1991","unstructured":"Yasaka M, Miyatake K, Mitani M, Beppu S, Nagata S, Yamaguchi T, Omae T: Intracardiac mobile thrombus and D-dimer fragment of fibrin in patients with mitral stenosis. Br Heart J. 1991, 66: 22-25.","journal-title":"Br Heart J"},{"key":"121_CR12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/blood.V70.2.343.343","volume":"70","author":"KA Bauer","year":"1987","unstructured":"Bauer KA, Rosenberg RD: The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation. Blood. 1987, 70: 343-350.","journal-title":"Blood"},{"key":"121_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0268-960X(90)90014-J","volume":"4","author":"MD Boisclair","year":"1990","unstructured":"Boisclair MD, Ireland H, Lane DA: Assessment of hypercoagulable states by measurement of activation fragments and peptides. Blood Rev. 1990, 4: 25-40. 10.1016\/0268-960X(90)90014-J.","journal-title":"Blood Rev"},{"key":"121_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1055\/s-2007-1002650","volume":"17","author":"D Tschoepe","year":"1991","unstructured":"Tschoepe D, Roesen P, Esser J, Schwippert B, Nieuwenhuis HK, Kehrel B, Gries FA: Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost. 1991, 17: 433-438.","journal-title":"Semin Thromb Hemost"},{"key":"121_CR15","first-page":"325","volume":"33","author":"J Maly","year":"1990","unstructured":"Maly J, Pecka M, Vodickova L, Pidrman V, Mala H, Blaha M, Jebavy L: Changes in the activity of thrombocytes by smoking. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove. 1990, 33: 325-333.","journal-title":"Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove"},{"key":"121_CR16","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/S0002-9378(87)80129-1","volume":"157","author":"J Bonnar","year":"1987","unstructured":"Bonnar J: Coagulation effects of oral contraception. Am J Obstet Gynecol. 1987, 157: 1042-1048.","journal-title":"Am J Obstet Gynecol"},{"key":"121_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000176648","volume":"85","author":"JJ Hwang","year":"1994","unstructured":"Hwang JJ, Ko FN, Li YH, Ma HM, Wu GJ, Chang H, Wang SM, Schie JT, Tseng YZ, Kuan P: Clinical implications and factors related to left atrial spontaneous echo contrast in chronic nonvalvular atrial fibrillation. Cardiology. 1994, 85: 69-75.","journal-title":"Cardiology"},{"key":"121_CR18","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1378\/chest.111.4.929","volume":"111","author":"G Pongratz","year":"1997","unstructured":"Pongratz G, Brandt-Pohlmann M, Henneke KH, Pohle C, Zink D, Gehling G, Bachmann K: Platelet activation in embolic and preembolic status of patients with nonrheumatic atrial fibrillation. Chest. 1997, 111: 929-933.","journal-title":"Chest"},{"key":"121_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/BF01146838","volume":"8","author":"S Rohmann","year":"1992","unstructured":"Rohmann S, Erbel R, Darius H, Makowski T, Jensen P, Fischer T, Meyer J: Spontaneous echo contrast imaging in infective endocarditis: a predictor of complications?. Int J Card Imaging. 1992, 8: 197-207. 10.1007\/BF01146838.","journal-title":"Int J Card Imaging"},{"key":"121_CR20","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1053\/euhj.2000.2515","volume":"22","author":"S Kamath","year":"2001","unstructured":"Kamath S, Blann AD, Lip GY: Platelet activation: assessment and quantification. Eur Heart J. 2001, 22: 1561-1571. 10.1053\/euhj.2000.2515.","journal-title":"Eur Heart J"}],"container-title":["Current Controlled Trials in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1468-6708-6-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1468-6708-6-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1468-6708-6-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1468-6708-6-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:31:06Z","timestamp":1728383466000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1468-6708-6-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,27]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["121"],"URL":"https:\/\/doi.org\/10.1186\/1468-6708-6-2","relation":{},"ISSN":["1468-6708","1468-6694"],"issn-type":[{"type":"print","value":"1468-6708"},{"type":"electronic","value":"1468-6694"}],"subject":[],"published":{"date-parts":[[2005,2,27]]},"assertion":[{"value":"20 December 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"2"}}